242 related articles for article (PubMed ID: 3937059)
1. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
Fozard JR; Zreika M; Robin M; Palfreyman MG
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):186-93. PubMed ID: 3937059
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
Fozard JR; Palfreyman MG; Robin M; Zreika M
Br J Pharmacol; 1986 Jan; 87(1):257-64. PubMed ID: 3082400
[TBL] [Abstract][Full Text] [Related]
3. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
[TBL] [Abstract][Full Text] [Related]
4. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
Youdim MB; Tipton KF
Parkinsonism Relat Disord; 2002 Mar; 8(4):247-53. PubMed ID: 12039419
[TBL] [Abstract][Full Text] [Related]
5. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
6. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
Kindt MV; Heikkila RE
Life Sci; 1986 Apr; 38(16):1459-62. PubMed ID: 3084895
[TBL] [Abstract][Full Text] [Related]
7. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
Finberg JP; Youdim MB
Br J Pharmacol; 1985 Jun; 85(2):541-6. PubMed ID: 3928010
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
Azam M; Jain S; Baquer NZ
Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
[TBL] [Abstract][Full Text] [Related]
9. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
Zreika M; McDonald IA; Bey P; Palfreyman MG
J Neurochem; 1984 Aug; 43(2):448-54. PubMed ID: 6736960
[TBL] [Abstract][Full Text] [Related]
10. Gonadal influences on the inhibition of monoamine oxidase type B activity.
Vaccari A; Biassoni R
J Neurosci Res; 1982; 8(1):13-9. PubMed ID: 6816948
[TBL] [Abstract][Full Text] [Related]
11. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
[TBL] [Abstract][Full Text] [Related]
12. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
Robinson JB
Biochem Pharmacol; 1985 Dec; 34(23):4105-8. PubMed ID: 3933519
[TBL] [Abstract][Full Text] [Related]
13. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
14. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G
J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
[TBL] [Abstract][Full Text] [Related]
15. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
Finnegan KT; Skratt JJ; Irwin I; DeLanney LE; Langston JW
Eur J Pharmacol; 1990 Aug; 184(1):119-26. PubMed ID: 2120076
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
17. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
Elliott J; Callingham BA; Barrand MA
J Pharm Pharmacol; 1989 Jan; 41(1):37-41. PubMed ID: 2565962
[TBL] [Abstract][Full Text] [Related]
18. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
19. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
20. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
Knoll J
Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
